Get the Stockscreener App
3.09
0.32%
-0.01
After Hours:
3.02
-0.07
-2.27%
Onconetix Inc stock is traded at $3.09, with a volume of 146.63K.
It is down -0.32% in the last 24 hours and down -36.02% over the past month.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
See More
Previous Close:
$3.10
Open:
$3.05
24h Volume:
146.63K
Relative Volume:
0.19
Market Cap:
$1.61M
Revenue:
-
Net Income/Loss:
$-53.12M
P/E Ratio:
-0.0284
EPS:
-108.8
Net Cash Flow:
$-15.86M
1W Performance:
+15.73%
1M Performance:
-36.02%
6M Performance:
-93.27%
1Y Performance:
-99.39%
1-Day Range:
$3.03
$3.21
1-Week Range:
$2.68
$3.21
52-Week Range:
$2.61
$656.88
Onconetix Inc Stock (ONCO) Company Profile
Name
Onconetix Inc
Sector
Industry
Phone
513-620-4101
Address
201 E. FIFTH STREET, CINCINNATI
Compare ONCO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONCO
Onconetix Inc
|
3.09 | 1.62M | 0 | -53.12M | -15.86M | -108.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.30 | 101.51B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.97 | 59.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.73 | 56.69B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
652.43 | 39.57B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
309.69 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Onconetix Inc Stock (ONCO) Latest News
RSI and MACD Indicate Shift in Onconetix Inc. SentimentJuly 2025 Opening Moves & Consistent Return Strategy Ideas - thegnnews.com
Onconetix, Inc. SEC 10-Q Report - TradingView
Onconetix Inc. stock trend forecast2025 Pullback Review & Short-Term Trading Opportunity Alerts - Newser
Price action breakdown for Onconetix Inc.Portfolio Return Summary & Low Drawdown Momentum Ideas - Newser
How to manage a losing position in Onconetix Inc.Quarterly Performance Summary & Community Trade Idea Sharing Platform - Newser
Has Onconetix Inc. formed a bullish divergence2025 Price Targets & High Return Stock Watch Alerts - Newser
Onconetix Director Resignation Amid Financial Adjustments - MSN
Comparing Onconetix Inc. in custom built stock radarsEarnings Miss & Smart Money Movement Tracker - Newser
Real time breakdown of Onconetix Inc. stock performanceJuly 2025 Review & Free Technical Pattern Based Buy Signals - Newser
Can Onconetix Inc. rally from current levelsPredictive Analytics for Equity Growth Potential - Newser
Using data models to predict Onconetix Inc. stock movementLoss Limitation Strategy Based on Analysis - Newser
Top Risks to Consider Before Buying Onconetix Inc. StockCapital Growth Plan for New Investors - Newser
Quantitative breakdown of Onconetix Inc. recent moveBuy and Hold Return Summary with Charts - Newser
Visualizing Onconetix Inc. stock with heatmapsTriple Digit Gain Opportunity Watchlist - Newser
How Onconetix Inc. stock performs during market volatilityFree Step-by-Step Trade Signal Implementation - Newser
Can machine learning forecast Onconetix Inc. recoveryEntry Confirmation Using Short-Term Forecasting - Newser
Is Onconetix Inc. forming a reversal patternTrend Reversal Watch with Entry Signals - Newser
Why Onconetix Inc. stock attracts strong analyst attentionWeekly Movement Forecast With Chart Signals - Newser
Applying Wyckoff theory to Onconetix Inc. stockDay Trading Plan with Entry Risk Management - Newser
When is the best time to exit Onconetix Inc.Weekly Breakout Forecast with Entry Zones - Newser
Live market analysis of Onconetix Inc.Historical Volatility and Pattern Breakdown Analysis - Newser
How volatile is Onconetix Inc. stock compared to the marketMaximize gains with proven stock analysis - Jammu Links News
Is Onconetix Inc. stock overvalued or undervaluedRecord-setting profit potential - Jammu Links News
Is Onconetix Inc. a growth stock or a value stockUnlock powerful stock screening for profits - Jammu Links News
How does Onconetix Inc. compare to its industry peersCapitalize on emerging trends for profits - Jammu Links News
What markets is Onconetix Inc. expanding into Is NHPAP stock a good long term investment optionCapitalize on emerging growth stocks - Jammu Links News
What is Onconetix Inc. company’s growth strategyUnmatched profit growth - Jammu Links News
Is it the right time to buy Onconetix Inc. stockBuild wealth steadily with smart trading - Jammu Links News
What institutional investors are buying Onconetix Inc. stockInvest in stocks with strong fundamentals - Jammu Links News
What is the dividend policy of Onconetix Inc. stockHigh-margin investment plays - Jammu Links News
When is Onconetix Inc. stock expected to show significant growthBreakout stock performance - Jammu Links News
What makes Onconetix Inc. stock price move sharplyBuild wealth faster with expert stock selection - Jammu Links News
What catalysts could drive Onconetix Inc. stock higher in 2025High-octane investment gains - Jammu Links News
Why is Onconetix Inc. stock attracting strong analyst attentionDiscover stock picks with superior returns - Jammu Links News
Onconetix Inc Stock (ONCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
1.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):